JDD Webinars

Recognizing the Role of The Sebaceous Gland in Acne

By October 6, 2020April 22nd, 2021No Comments

Featured Article

Recognizing The Role of the Sebaceous Gland in Acne

The Role of Androgen Receptors in the Development and Management of Acne Vulgaris

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Faculty


Leon H. Kircik, MD

Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


James Q. Del Rosso, DO, FAOCD, FAAD

Research Director & Principal Investigator
JDR Dermatology Research
Thomas Dermatology
Las Vegas, Nevada

You May Also Like

JDD in the News: Dapsone Gel for Acne Patients with Skin of Color; Combination Therapy for Atrophic Acne Scars

| Acne, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
by Allison Sit Healio covered three studies from the June issue of the Journal of Drugs in Dermatology, including one about dapsone gel for acne patients with skin of color.…

JDD in the News: Skincare Regimen for EBD Treatment; Barriers to Melanoma Immunotherapy

| Featured Articles, JDD Highlights, JDD in the Media, Skin Cancer, The Latest | No Comments
by Allison Sit Three studies from the May issue of the Journal of Drugs in Dermatology are already making news. Healio wrote about a skincare regimen that can address adverse…

JDD in the News: Efficacy and Tolerability of Stabilized, Bioactive Retinol

| Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
by Allison Sit Dermatology Times, HAPPI, Healio and HealthDay all wrote about an April article in the Journal of Drugs in Dermatology that was one of one of the largest,…

Leave a Reply